/CNW/ - Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for VELSIPITY™. A once-daily oral treatment, VELSIPITY is...
These two pharma stocks have followed distinct paths of late. Which is the better investment?
This Vanguard growth fund is home to some of the world's most innovative companies.
/CNW/ - During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing...
A little up-front investment can go a long way with these three stocks.
The answer to that question will either make you wince or smile.
A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
/CNW/ - On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is...
Analysts at Goldman Sachs think these 5 underperforming stocks could be poised to outperform, thanks to a healthy valuation discount and expected EPS growth.
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?